Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 501–600 of 1,000
Letourneau, L. R., & Greeley, S. A. W. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1175-9 · Cited by 25
Hanley, K. P., Hearn, T., Berry, A. A., Carvell, M. J., Patch, A., Williams, L. J., Sugden, S. A., Wilson, D. I., Ellard, S., & Hanley, N. A. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0120 · Cited by 26
“There is a clear involvement of mutations in the pathway between the ATP-sensitive potassium channel and insulin secretion as causes of permanent neonatal diabetes (Gloyn et al. 2004).”
Self-citationKim, M. S., Kim, S. Y., Kim, G.-H., Yoo, H. W., Lee, D. W., & Lee, D. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.4.616 · Cited by 24
“(3) reported that heterozygous activating mutations in the KCNJ11 gene are a common cause of PND.”
BackgroundNguyen, L. M., Pozzoli, M., Hraha, T. H., & Benninger, R. K. P. (2014) · Diabetes · doi:10.2337/db13-1048 · Cited by 23
“To summarize, we have shown that by reducing gap junction coupling between b-cells in a model of NDM caused by expression of ATP-insensitive KATP channels, we can eliminate severe hyperglycemia and islet dysfunction.”
BackgroundInfluentialClinical implications of mineralocorticoid receptor overactivation
Mouhayyar, C. E., Chhikara, M., Tang, M., & Nigwekar, S. U. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae346 · Cited by 26
“In addition, hypokalemia can lead to symptoms such as fatigue, weakness, cramps, constipation, pal-pitations, or numbness and can impair insulin secretion and glucose metabolism through the ATP-sensitive potassium ( K ATP ) channel in islet cells, leading to hyperglycemia and diabetes [23 , 24 ].”
Passone, C., Giani, E., Vaivre‐Douret, L., Kariyawasam, D., Berdugo, M., Garcin, L., Beltrand, J., Bernardo, W. M., & Polak, M. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13376 · Cited by 23
“KATP channels are also found in neurons and muscle cells.(5,11,12) Neurological abnormalities may be present in up to 20% of patients with KCNJ11 mutations and a smaller proportion of patients with ABCC8 mutations.”
BackgroundThe Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results
RADIANT Study Group, Balasubramanyam, A., REDONDO, M. J., Craigen, W. J., Dai, H., DAVIS, A. E., Desai, D., Dussan, M., Faruqi, J., Gaba, R., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2440 · Cited by 23
Monogenic and Other Unusual Causes of Diabetes Mellitus
Nakhla, M., & Polychronakos, C. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.005 · Cited by 23
“These features include a prominent metopic suture, bilateral ptosis, downturned mouth, and limb contractures [21].”
BackgroundInfluentialLaborie, L. B., Mackay, D., Temple, I. K., Molven, A., Sövik, O., & Njølstad, P. R. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-009-1008-y · Cited by 23
“A further 20–25% of the TNDM cases are due to heterozygous mutations in the beta cell genes KCNJ11 [ 6 ], ABCC8 [1], or HNF1B [17].”
BackgroundSelf-citationFunctional analysis of two Kir6.2 ( KCNJ11 ) mutations, K170T and E322K, causing neonatal diabetes
Tarasov, A. I., Girard, C. A. J., Larkin, B., Tammaro, P., Flanagan, S. E., Ellard, S., & Ashcroft, F. M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00777.x · Cited by 24
Self-citationInteractions between genetic background, insulin resistance and β‐cell function
Kahn, S. E., Suvag, S., Wright, L. A.-C., & Utzschneider, K. M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01650.x · Cited by 28
“On the other hand, mutations that result in the channel remaining open even in the presence of glucose result in reduced insulin secretion and permanent neonatal diabetes, a condition not associated with the development of antibodies as found in type 1 diabetes [62,63].”
BackgroundBarone, J. V., Tillman, E. M., & Ferry, R. J. (2011) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-16.4.291 · Cited by 24
Wang, D., Chen, X., Yang, Y., & Liu, C.-X. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.03.004 · Cited by 23
Stimulus-Secretion Coupling in Beta-Cells: From Basic to Bedside
Islam, M. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_37 · Cited by 26
Hvidøre Study Group on Childhood Diabetes, Pörksen, S., Laborie, L. B., Nielsen, L. B., Andersen, M. L. M., Sandal, T., de Wet, H., Schwarcz, E., Åman, J., Swift, P. G. F., et al. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-16 · Cited by 27
“Mutation in ABCC8 We screened both the KCNJ11 and ABCC8 genes in all 24 subjects negative for autoantibodies (IA-2A, GADA and/or ICA) at one month after diagnosis.”
BackgroundSelf-citationVariable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation
D’Amato, E., Tammaro, P., Craig, T. J., Tosi, A., Giorgetti, R., Lorini, R., & Ashcroft, F. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02443.x · Cited by 25
Self-citationMashanov, G. I., Nobles, M., Harmer, S. C., Molloy, J. E., & Tinker, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039974 · Cited by 27
Monogenic diabetes: implications for therapy of rare types of disease
Malecki, M. T., & Mlynarski, W. M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00736.x · Cited by 32
DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
Cho, J. H., Kang, E., Lee, B. H., Kim, G.-H., Choi, J., & Yoo, H. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.6.1042 · Cited by 22
“R201H mutation, which was found in our patient, exhibit a marked sensitivity to inhibition by tolbutamide (4).”
BackgroundBalasubramanian, M., Hamilton-Shield, J. P., Acerini, C. L., Walker, J., Ellard, S., Marchand, M., Polak, M., Vaxillaire, M., Crolla, J. A., Bunyan, D. J., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33194 · Cited by 22
Self-citationHamilton-Shield, J. P. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096354 · Cited by 22
Pas de deux in groups of four—the biogenesis of K channels
Neagoe, I., & Schwappach, B. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.023 · Cited by 23
Exploring the Pathophysiology of ATP-Dependent Potassium Channels in Insulin Resistance
Rodríguez-Rivera, N. S., & Barrera‐Oviedo, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074079 · Cited by 23
“Nevertheless, gain-of-function mutations keep the channels open and beta cells hyperpolarized, thereby decreasing insulin secretion [74].”
BackgroundStratified medicine: drugs meet genetics
Hall, I. P. (2013) · European Respiratory Review · doi:10.1183/09059180.00008312 · Cited by 22
Insights into the Genetics and Signaling Pathways in Maturity-Onset Diabetes of the Young
Sousa, M., Rego, T., & Bruges‐Armas, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112910 · Cited by 24
“They concluded that neonatal diabetes was caused by heterozygous mutations of the KCNJ11, with variable onset and the severity of diabetes [148].”
Backgroundα-cell electrophysiology and the regulation of glucagon secretion
Gao, R., Acreman, S., Ma, J., Abdulkader, F., Wendt, A., & Zhang, Q. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0295 · Cited by 29
Li, A., & Meyre, D. (2014) · Current Psychiatry Reviews · doi:10.2174/1573400510666140630170549 · Cited by 28
Sövik, O., Aagenæs, Ø., Eide, S. Å., Mackay, D., Temple, I. K., Molven, A., & Njølstad, P. R. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00776.x · Cited by 21
“A new era started when treatment with sulfonylurea could be linked to specific genetic defects in neonatal diabetes (23, 24).”
BackgroundSelf-citationLoechner, K. J., Akrouh, A., Kurata, H. T., Dionisi‐Vici, C., Maiorana, A., Pizzoferro, M., Rufini, V., de Goyet, J. D. V., Colombo, C., Barbetti, F., et al. (2010) · Diabetes · doi:10.2337/db10-0731 · Cited by 25
Boodhansingh, K. E., Kandasamy, B., Mitteer, L., Givler, S., León, D. D. D., Shyng, S., Ganguly, A. A., & Stanley, C. A. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61335 · Cited by 21
“…is particularly a problem with novel missense KATP channel variants, since these can potentially be benign polymorphisms, recessive inactivating mutations, dominant inactivating mutations, or even dominant diabetes-causing mutations (Babenko et al., 2006; Gloyn et al., 2004; Snider et al., 2013).”
BackgroundGlucose Homeostasis in Newborns: An Endocrinology Perspective
Tas, E., GARIBALDI, L. R., & Muzumdar, R. H. (2020) · NeoReviews · doi:10.1542/neo.21-1-e14 · Cited by 26
He, B., Li, X., & Zhou, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13114 · Cited by 23
“2 and SUR1) is expressed in brain, cardiac muscle, and skeletal muscle in addition to β-cells, KCNJ11 gene mutations can also cause developmental delay and neurological features (developmental delay, epilepsy, and neonatal diabetes [DEND] syndrome and intermediate DEND [iDEND] syndrome).(4,22) DEND syndrome represents…”
BackgroundAka, T. D., Saha, U., Shati, S. A., Aziz, M. A., Begum, M., Hussain, M. S., Millat, M. S., Uddin, M. S., & Islam, M. S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08376 · Cited by 21
Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes
Marucci, A., Rutigliano, I., Fini, G., Pezzilli, S., Menzaghi, C., Paola, R. D., & Trischitta, V. (2022) · Genes · doi:10.3390/genes13010117 · Cited by 25
“Conversely, nearly 100 dominant and only one recessive activating KCNJ11 mutations have been linked to neonatal diabetes [15,41].”
BackgroundAntidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATPchannels
Geng, X., Li, L., Bottino, R., Balamurugan, A. N., Bertera, S., Densmore, E., Su, A.-J. A., Chang, Y., Trucco, M., & Drain, P. F. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00016.2007 · Cited by 24
Manna, T. D., Battistim, C., Radonsky, V., Savoldelli, R. D., Damiani, D., Kok, F., Pearson, E. R., Ellard, S., Hattersley, A. T., & Reis, A. F. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000800024 · Cited by 22
“Defects in several other genes (IPF1, GCK, HNF1B, INS, FOXP3, EIF2AK3) have also been implicated in PNDM (4,9), however the activating mutations of KCNJ11, which reduce the ability for ATP to close the ATP-sensitive potassium channel (KATP), are the most common (6).”
BackgroundSelf-citationLight, P. E. (2010) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s6969 · Cited by 26
“)(4) 2) A decrease in ATP-binding affinity.(51,85,86) Homomeric channels containing mutations in the ATP-binding region (eg, R201C)(4) display altered ATP”
Genomic medicine at the heart of diabetes management
McCarthy, M. I. (2015) · Diabetologia · doi:10.1007/s00125-015-3588-6 · Cited by 21
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function
Cordiner, R. L. M., Mari, A., Tura, A., & Pearson, E. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab151 · Cited by 22
“Patients with neonatal diabetes due to activating mutations in the genes encoding the Katp channel provide potential insight into the role of the triggering pathway and potential interaction with incretin action (7-10).”
BackgroundSelf-citationPathogenesis of the Metabolic Syndrome: Insights from Monogenic Disorders
Murphy, R., Carroll, R. W., & Krebs, J. D. (2013) · Mediators of Inflammation · doi:10.1155/2013/920214 · Cited by 25
Personalized Prognosis and Diagnosis of Type 2 Diabetes – Vision or Fiction?
Müller, G. A. (2010) · Pharmacology · doi:10.1159/000283780 · Cited by 26
Epidemiology, clinical characteristics, and genetic etiology of neonatal diabetes in Japan
Nagashima, K., Tanaka, D., & Inagaki, N. (2017) · Pediatrics International · doi:10.1111/ped.13199 · Cited by 20
Neonatal diabetes: A case series
Ganesh, R., Suresh, N., Vasanthi, T., & Ravikumar, K. G. (2016) · Indian Pediatrics · doi:10.1007/s13312-017-0993-6 · Cited by 20
“Molecular genetic testing has a big impact on management of NDM as switching over to oral sulfonyl urea is required in children with KCNJ11/ABCC 8 gene mutation.”
BackgroundInfluentialRORB and RORC associate with human islet dysfunction and inhibit insulin secretion in INS-1 cells
Taneera, J., Mohammed, A. K., Dhaiban, S., Hamad, M. A., Prasad, R. B., Sulaiman, N. D., & Salehi, A. A. (2019) · Islets · doi:10.1080/19382014.2019.1566684 · Cited by 20
“Electrifying dysmorphology”: Potassium channelopathies causing dysmorphic syndromes
Hamilton, M., & Suri, M. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.03.002 · Cited by 20
The KATP Channel and Neonatal Diabetes
Shimomura, K. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-160 · Cited by 20
Control of Kir channel gating by cytoplasmic domain interface interactions
Borschel, W. F., Wang, S., Lee, S.-J., & Nichols, C. G. (2017) · The Journal of General Physiology · doi:10.1085/jgp.201611719 · Cited by 20
“2 or SUR1 result in maintained β cell hyperpolarization, leading to inhibition of insulin secretion, and neonatal diabetes mellitus (Koster et al., 2000; Gloyn et al., 2004).”
BackgroundCongenital forms of diabetes: the beta-cell and beyond
Letourneau, L. R., & Greeley, S. A. W. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.01.005 · Cited by 20
“com mutations) was published less than 15 years ago [1].”
BackgroundEdghill, E. L., Minton, J. A. L., Groves, C. J., Flanagan, S. E., Patch, A., Rubio‐Cabezas, O., Shepherd, M. H., Lenzen, S., McCarthy, M. I., Ellard, S., et al. (2016) · PubMed · doi:10.6092/1590-8577/3864 · Cited by 20
“Many of the known monogenic diabetes genes were identified as biological candidates involved in beta cell development, maintenance and function, such as GCK, KCNJ11, IPF1 and PTF1A [4, 5, 6, 7, 8].”
BackgroundSelf-citationDorothy Hodgkin Lecture 2010^. From hype to hope? A journey through the genetics of Type 2 diabetes
McCarthy, M. I. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03194.x · Cited by 23
Männikkö, R., Jefferies, C., Flanagan, S. E., Hattersley, A. T., Ellard, S., & Ashcroft, F. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp554 · Cited by 20
“2 and SUR1, respectively, are associated with neonatal diabetes neonatal diabetes (6,7), a rare genetic disease characterized by elevated blood glucose levels within the first 6 months of life.”
BackgroundSelf-citationType 2 Diabetes: Hypoinsulinism, Hyperinsulinism, or Both?
Gläser, B. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040148 · Cited by 19
“, testing the hypothesis that the primary defect caused by these genes results in decreased insulin secretion [”
Khatami, F., Mohajeri‐Tehrani, M. R., & Tavangar, S. M. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190228102212 · Cited by 21
Männikkö, R., Stansfeld, P. J., Ashcroft, A. S., Hattersley, A. T., Sansom, M. S. P., Ellard, S., & Ashcroft, F. M. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.209700 · Cited by 20
“2 or SUR1 subunits of the ATP-sensitive potassium (KATP) channel are a common cause of neonatal diabetes, a rare inherited disorder characterised by the development of diabetes within the first 6 months of life (Gloyn et al. 2004; Proks et al. 2004; Hattersley & Ashcroft, 2005; Babenko et al. 2006; Ashcroft, 2007).”
BackgroundSelf-citationQubbaj, W., Alswaid, A. F., Hassan, S. S. M., Awartani, K. A., Deek, H., & Coşkun, S. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.09.016 · Cited by 19
“2 (KCNJ11) encoding the b-cell plasma membrane ATP-sensitive potassium channel have been widely reported (Nestorowicz et al., 1996, 1997; Thomas et al., 1995, 1996; Gloyn et al., 2004; Sagen et al., 2004; Vaxillaire et al., 2004; Hattersley et al., 1998; Hattersley and Tooke, 1999).”
BackgroundPharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
Mousa, S. A. (2009) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s5806 · Cited by 20
Gaál, Z., Klupa, T., Kántor, I., Mlynarski, W. M., Albert, L., Tołłoczko, J., Balogh, I., Czajkowski, K., & Malecki, M. T. (2012) · Diabetes Care · doi:10.2337/dc12-0163 · Cited by 18
Insulin pump therapy in transient neonatal diabetes mellitus
Park, J. H., Kang, J. H., Lee, K.-H., Kim, N.-H., Yoo, H., Lee, D., & Yoo, E.-G. (2013) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2013.18.3.148 · Cited by 18
Understanding childhood diabetes mellitus: new pathophysiological aspects
Grulich‐Henn, J., & Klose, D. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0120-9 · Cited by 21
“The first description of activating mutations in the KCNJ11 gene, encoding for the Kir 6.2 subunit ATP-sensitive potassium-channel, also designated sulfonylurea receptors by Gloyn et al, was a hallmark in the understanding and treatment of neonatal diabetes mellitus (Gloyn et al 2004).”
BackgroundInfluentialSachse, G., Haythorne, E., Hill, T., Proks, P., Joynson, R., Terrón-Expósito, R., Bentley, L., Tucker, S. J., Cox, R., & Ashcroft, F. M. (2021) · Diabetes · doi:10.2337/db20-0691 · Cited by 19
Self-citationPharmacological Approaches to Studying Potassium Channels
Mathie, A. A., Veale, E. L., Golluscio, A., Holden, R. G., & Walsh, Y. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_502 · Cited by 20
Edghill, E. L., & Hattersley, A. T. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_19 · Cited by 18
Self-citationLin, Y.-W., Li, A., Grasso, V., Battaglia, D., Crinò, A., Colombo, C., Barbetti, F., & Nichols, C. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063758 · Cited by 18
“Thus the patient could be categorized as exhibiting an intermediate DEND phenotype [4], and consistent with the gain-of-function phenotype Unique Kir6.”
BackgroundInfluentialNeonatal Physiology and Metabolic Considerations
Pierro, A., Eaton, S. D., & Ong, E. G. P. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02842-4.50009-7 · Cited by 19
Alkorta‐Aranburu, G., SUKHANOVA, M. J., Carmody, D., Hoffman, T. L., Wysinger, L., Keller‐Ramey, J., Li, Z., Johnson, A. K., Kobiernicki, F., Botes, S., et al. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0341 · Cited by 20
Intellectual Disability in KATP Channel Neonatal Diabetes
Svalastoga, P., Sulen, Å., Fehn, J. R., Aukland, S. M., Irgens, H. U., Sirnes, E., Fevang, S. K. E., Valen, E., Elgen, I. B., & Njølstad, P. R. (2020) · Diabetes Care · doi:10.2337/dc19-1013 · Cited by 18
Self-citationSayed, S., & Nabi, A. H. M. N. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_518 · Cited by 21
KCNJ11 knockout morula re-engineered by stem cell diploid aggregation
Nelson, T. J., Martinez‐Fernandez, A., & Terzic, A. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0179 · Cited by 19
Cauchi, S., Vaxillaire, M., Choquet, H., Durand, E., Duval, A., Polak, M., & Froguel, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0505-z · Cited by 18
“Dominant activating mutations in the KCNJ11 gene [ 1 , 2], which encodes the inwardly rectifying Kir6.2 subunit of the ATP-sensitive potassium (KATP) channel expressed at the surface of the pancreatic beta cell, or in the ABCC8 gene [3], which encodes the SUR1 regulatory subunit of the channel, account for more than 3…”
BackgroundKATP Channel Function: More than Meets the Eye
Shyng, S. (2022) · Function · doi:10.1093/function/zqab070 · Cited by 17
Identification of KCNJ11 as a functional candidate gene for bovine meat tenderness
Tizioto, P. C., Gasparin, G. R., de Souza, M. M., Mudadu, M. A., Coutinho, L. L., Mourão, G. B., Tholon, P., Meirelles, S. L. C., Túllio, R. R., Rosa, A. N., et al. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00137.2012 · Cited by 17
Borowiec, M., Antosik, K., Fendler, W. M., Deja, G., Jarosz-Chobot, P. A., Myśliwiec, M., Zmysłowska, A., Malecki, M. T., Szadkowska, A., & Mlynarski, W. M. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01656.x · Cited by 17
Shimomura, K., de Nanclares, G. P., Foutinou, C., Caimari, M., Castaño, L. A., & Ashcroft, F. M. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02901.x · Cited by 17
Self-citationBarber, T. M., Bennett, A. J., Gloyn, A. L., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Taponen, S., Weedon, M. N., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201802 · Cited by 20
Self-citationTrafficking of ATP-sensitive potassium channels in health and disease
Sivaprasadarao, A., Taneja, T. K., Mankouri, J., & Smith, A. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351055 · Cited by 22
Gläser, B. (2008) · Diabetes · doi:10.2337/db08-0116 · Cited by 19
“Activating mutations in either of the two subunits of the -cell ATPsensitive K channel, ABCC8 and KCNJ11, are more frequently seen (4,5).”
BackgroundGach, A., Wyka, K., Malecki, M. T., Noczyńska, A., SKUPIEN, J. K., Nazim, J., Szalecki, M., Bodalski, J., Sieradzki, J., & Mlynarski, W. M. (2007) · Diabetes Care · doi:10.2337/dc06-2440 · Cited by 17
Hamilton-Shield, J. P., Flanagan, S. E., Mackay, D., Harries, L. W., Proks, P., Girard, C. A. J., Ashcroft, F. M., Temple, I. K., & Ellard, S. (2007) · Diabetes · doi:10.2337/db07-0999 · Cited by 20
“Recently, Gloyn and colleagues described activating mutations in KCNJ11 as the cause of many cases of permanent (9) and a few cases of transient (10) neonatal diabetes: this has been confirmed in a large followup series (5; 11).”
BackgroundMethodSelf-citationNot the second fiddle: α cell development, identity, and function in health and diabetes
Brooks, E. P., & Sussel, L. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0297 · Cited by 21
Velde, C. D., Molnes, J., Berland, S., Njølstad, P. R., & Molven, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae459 · Cited by 17
Self-citationJiang, Y., Chuang, L., Pei, D., Lee, Y., Wei, J.-N., Sung, F., & Chang, T. (2014) · International Journal of Endocrinology · doi:10.1155/2014/983016 · Cited by 18
“In children, one recent study indicated that six single nucleotide polymorphisms, including an activating R201H mutation on KCNJ11 gene, contribute to permanent neonatal diabetes [42].”
BackgroundGenetic basis of β‐cell dysfunction in man
Groop, L., & Lyssenko, V. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01117.x · Cited by 19
Notary, A. M., Westacott, M. J., Hraha, T. H., Pozzoli, M., & Benninger, R. K. P. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005116 · Cited by 18
“Mutations to these sub-units often result in reduced sensitivity to ATP and increased open channel stability [14,16–22]; thereby limiting electricalactivity and insulin secretion.”
Bérard, A., Levin, M. G., Sadler, T. W., & Healy, D. T. (2018) · Bioelectricity · doi:10.1089/bioe.2018.0003 · Cited by 18
Molecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes
Caballero, L. S., Gorgogietas, V. A., Arroyo, M. N., & Igoillo‐Esteve, M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.005 · Cited by 16
Dalgin, G., Tryba, A. K., Cohen, A. P., Park, S.-Y., Philipson, L. H., Greeley, S. A. W., & Garcia, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00939-7 · Cited by 17
The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities
Rica, I., Luzuriaga, C., de Nanclares, G. P., Estalella, I., Aragonés, Á., Barrio, R., Bilbao, J. R., Carlés, C., Fernández, C., Fernández, J. M., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02140.x · Cited by 18
Craig, T. J., Shimomura, K., Holl, R. W., Flanagan, S. E., Ellard, S., & Ashcroft, F. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0159 · Cited by 19
Self-citationGenetic factors in pathogenesis of diabetes mellitus after kidney transplantation
Tarnowski, M., Słuczanowska-Głąbowska, S., Pawlik, A., Mazurek−Mochol, M., & Dembowska, E. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s129327 · Cited by 17
“Mutations in the KCNJ11 gene are associated with defective insulin secretion and development of diabetes mellitus.(59,60)”
Beta‐cell excitability and excitability‐driven diabetes in adult Zebrafish islets
Emfinger, C. H., Lőrincz, R., Wang, Y., York, N., Singareddy, S. S., Iklé, J. M., Tryon, R. C., McClenaghan, C., Shyr, Z. A., Huang, Y., et al. (2019) · Physiological Reports · doi:10.14814/phy2.14101 · Cited by 18
ATP-Sensitive K+ Channel Signaling in Glucokinase-Deficient Diabetes
Remedi, M. S., Koster, J. C., Patton, B. L., & Nichols, C. G. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2925 · Cited by 18
“As with the now dramatically improved treatment options for KATPinduced permanent neonatal diabetes (21,24), we suggest that there may be a role for sulfonylurea therapy in permanent neonatal diabetes resulting from glucokinase deficiency (13).”
BackgroundA syndrome of congenital hyperinsulinism and rhabdomyolysis is caused by KCNJ11 mutation
Albaqumi, M. N., Alhabib, F. A., Shamseldin, H. E., Mohammed, F., & Alkuraya, F. S. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102085 · Cited by 15
Gao, J. H., McClenaghan, C., Matreyek, K. A., Grange, D. K., & Nichols, C. G. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001659 · Cited by 19
“, 2002) and neonatal diabetes (Koster et al., 2000; Gloyn et al., 2004; Babenko et al., 2006), respectively.”
Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene
Vendramini, M. F., Gurgel, L. C., & Moisés, R. S. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000800003 · Cited by 15
Neonatal diabetes mellitus: current perspective
Shah, B. C., Kataria, A., Gopi, R. P., & Mally, P. (2014) · Research and Reports in Neonatology · doi:10.2147/rrn.s38206 · Cited by 18
A mutation causing increased KATP channel activity leads to reduced anxiety in mice
Lahmann, C., Clark, R. H., Iberl, M., & Ashcroft, F. M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.031 · Cited by 16
Self-citationSulfonylurea-Responsive Diabetes in Childhood
Landau, Z., Wainstein, J., Hanukoglu, A., Tuval, M., Lavie, J., & Gläser, B. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.004 · Cited by 16
Transforming lives: transferring patients with neonatal diabetes from insulin to sulphonylureas
Shepherd, M. H. (2006) · European Diabetes Nursing · doi:10.1002/edn.60 · Cited by 15
Waterfield, T., & Gloyn, A. L. (2008) · Pediatric Health · doi:10.2217/17455111.2.4.517 · Cited by 18
Self-citationNyangabyaki, C., Muhame, R. M., & Bahendeka, S. (2016) · African Health Sciences · doi:10.4314/ahs.v15i4.37 · Cited by 16
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.